NDC codes

401334 NDC codes with hospital pricing data in the network.

• NDC 65219057001 — BUMETANIDE 0.25 MG/ML INJECTION SOLN (131 hospitals, 890–3,446 samples)
• NDC 00270-1111-02 — GADOTERIDOL 279.3 MG/ML INTRAVENOUS SOLUTION (72 hospitals, 3,184–3,445 samples)
• NDC 00641601401 — dilTIAZem 5 mg/mL Soln 10 mL VIAL (138 hospitals, 3,307–3,442 samples)
• NDC 55150042701 — DILTIAZEM HCL 125 MG 25ML IV SOLN (55 hospitals, 3,307–3,442 samples)
• NDC 55150042710 — DILTIAZEM HCL 125 MG/25ML IV SOLN (51 hospitals, 3,307–3,442 samples)
• NDC 00143-9335-01 — BUPIVACAINE (PF) 0.75 % (7.5 MG/ML) INJ SOLN (8 hospitals, 3,438 samples)
• NDC 00407-1413-25 — IOHEXOL 300MG/ML 50ML INJ (5 hospitals, 3,293–3,437 samples)
• NDC 00407-1413-50 — IOHEXOL 300MG/ML 50ML INJ (5 hospitals, 3,293–3,437 samples)
• NDC 00407-1413-66 — OMNIPAQUE 300-399 (CT) PER ML (26 hospitals, 3,293–3,437 samples)
• NDC 00407-1413-68 — IOHEXOL 300MG/ML 50ML INJ (5 hospitals, 3,293–3,437 samples)
• NDC 00407-1413-90 — IOHEXOL 300MG/ML 50ML INJ (5 hospitals, 3,293–3,437 samples)
• NDC 10019-0179-63 — MORPHINE 100MG/100ML PB (9 hospitals, 2,780–3,437 samples)
• NDC 19515090441 — FLU VACCINE TS 2025-26(6MOS UP)(PF) 45 MCG(15MCG X3)/0.5 ML IM SYRINGE (123 hospitals, 3,356–3,437 samples)
• NDC 264775110 — DEXTROSE 5 % AND LACTATED RINGERS (UW) (59 hospitals, 3,263–3,434 samples)
• NDC 00641-6057-01 — MIDAZOLAM HCL 2 MG/2ML IJ SOLN (104 hospitals, 2,316–3,432 samples)
• NDC 70092109337 — NDC Description Not Available (86 hospitals, 2,172–3,432 samples)
• NDC 00404-6512-05 — LIDOCAINE 2 % W/EPI DENTAL SYRG-OR (17 hospitals, 3,305–3,431 samples)
• NDC 00641605601 — NDC Description Not Available (86 hospitals, 1,478–3,431 samples)
• NDC 00409672711 — MAGNESIUM SULFATE 1 GRAM/100 ML IN DEXTROSE 5 % INTRAVENOUS PIGGYBACK (50 hospitals, 1,512–3,429 samples)
• NDC 25021061281 — MAGNESIUM SULFATE 2 GRAM/50 ML (4 %) IN WATER INTRAVENOUS PIGGYBACK (133 hospitals, 2,042–3,428 samples)
• NDC 70594011702 — BUPIVACAINE (PF) 0.5 % (5 MG/ML) INJECTION SOLUTION (76 hospitals, 2,042–3,428 samples)
• NDC 00409130403 — HYDROMORPHONE 4 MG/ML INJECTION SYRINGE (43 hospitals, 941–3,425 samples)
• NDC 70121171901 — MAGNESIUM SULFATE 2 GM/50ML IV SOLN (83 hospitals, 1,876–3,424 samples)
• NDC 59651048805 — PREDNISONE 20 MG TABLET (18 hospitals, 2,865–3,423 samples)
• NDC 00703011003 — HYDROMORPHONE HCL PF 10 MG/ML IJ SOLN (110 hospitals, 1,451–3,422 samples)
• NDC 338004918 — sodium chloride 0.9 Soln-IV 100 mL (71 hospitals, 2,908–3,421 samples)
• NDC 00641621101 — MIDAZOLAM HCL INJ 10 MG/2ML (BASE EQUIVALENT),MIDAZOLAM HCL INJ 25 MG/5ML (BASE EQUIVALENT),MIDAZOLAM HCL INJ 5 MG/ML (BASE EQUIVALENT),MIDAZOLAM HCL INJ 50 MG/10ML (BASE EQUIVALENT),MIDAZOLAM HCL INJ PF 10 MG/2ML (BASE EQUIVALENT),MIDAZOLAM HCL INJ PF 5 MG/ML (BASE EQUIVALENT) (50 hospitals, 1,477–3,421 samples)
• NDC 00121-0854-16 — SULFAMETHOXAZOLE 200 MG-TRIMETHOPRIM 40 MG/5 ML ORAL SUSPENSION (67 hospitals, 3,301–3,418 samples)
• NDC 42023-0315-01 — EPINEPHRINE IN 0.9 % SOD CHLOR 4 MG/250 ML (16 MCG/ML) IV SOLN (49 hospitals, 3,301–3,418 samples)
• NDC 67618-0150-17 — povidone iodine 10% soln - 480 mL btl. (17 hospitals, 3,301–3,418 samples)
• NDC 990798437 — Sodium Chloride IV Soln 0.9% (62 hospitals, 2,922–3,417 samples)
• NDC 338004938 — Sodium Chloride (87 hospitals, 2,939–3,407 samples)
• NDC 63323032820 — NAFCILLIN 2 GRAM INJ SOLR IM (169 hospitals, 3,398–3,407 samples)
• NDC 00009540001 — NICOTINE 10 MG IN INHA (43 hospitals, 3,315–3,405 samples)
• NDC 45802025735 — MOMETASONE FUROATE 0.1 % EX CREA (121 hospitals, 3,322–3,403 samples)
• NDC 00409128303 — HYDROMORPHONE 2 MG INJ (FC) (188 hospitals, 973–3,403 samples)
• NDC 00409-1754-10 — MAGNESIUM SULFATE 500 MG/ML (50 %) INJ SYRG (70 hospitals, 2,151–3,402 samples)
• NDC 63323046701 — Sensorcaine 0.5% Vial (89 hospitals, 2,079–3,402 samples)
• NDC 00264-3105-11 — INJECTION, CEFAZOLIN SODIUM, 500 MG (124 hospitals, 2,762–3,401 samples)
• NDC 72572-0432-10 — MIDAZOLAM 1 MG/ML INJECTION SOLUTION (11 hospitals, 3,347–3,401 samples)
• NDC 00409672909 — MAGNESIUM SULFATE 40 GRAM/1,000 ML (4 %) IN WATER INTRAVENOUS SOLUTION (98 hospitals, 1,520–3,401 samples)
• NDC 00409-1159-09 — BUPIVACAINE (PF) 0.25 % (2.5 MG/ML) INJ SOLN (35 hospitals, 3,220–3,400 samples)
• NDC 00186-1199-41 — UNCLASSIFIED DRUGS (18 hospitals, 2,642–3,398 samples)
• NDC 70069075301 — BUPIVACAINE HCL 0.5 % (5 MG/ML) INJECTION SOLUTION (46 hospitals, 2,039–3,398 samples)
• NDC 00409-1746-10 — BUPIVACAINE-EPINEPHRINE (PF) 0.25% -1:200000 INJ SOLUTION (83 hospitals, 2,964–3,396 samples)
• NDC 72572-0171-10 — FENTANYL (PF) 50 MCG/ML INJECTION SOLUTION (4 hospitals, 3,097–3,394 samples)
• NDC 72266-0161-01 — OXALIPLATIN 5 MG/ML INTRAVENOUS SOLUTION (WRAPPER) (10 hospitals, 3,365–3,392 samples)
• NDC 50227103005 — Lidocaine Inj 2% w/ Epinephrine-1:100000 (101 hospitals, 1,707–3,390 samples)
• NDC 63323-0276-02 — HEPARIN, PORCINE (PF) 1,000 UNIT/ML INJECTION SOLUTION (87 hospitals, 3,020–3,389 samples)
• NDC 00409492834 — CALCIUM CHLORIDE 10 % IV SOLN (178 hospitals, 3,340–3,385 samples)